# US 2024/0173568 A1 · Systems and methods for shuttle mode radiation delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0173568 A1
- Document ID: US20240173568A1
- Status: Published application
- Kind: A1
- Application number: 18/480,900
- Filed: 2023-10-04
- Published: 2024-05-30
- Earliest claimed: 2017-09-22
- Assignees: RefleXion Medical, Inc.
- Applicants: RefleXion Medical, Inc.
- Inventors: Debashish PAL; Ayan MITRA; Christopher Eric BROWN; Peter Demetri OLCOTT; Yevgen VORONENKO; Rostem BASSALOW
- Web page: https://patentgrep.com/patent/US20240173568A1

## CPC

- A61N 5/1031: {using a specific method of dose optimization}
- A61N 5/1001: {using radiation sources introduced into or applied onto the body; brachytherapy}
- A61N 5/1045: {using a multi-leaf collimator, e.g. for intensity modulated radiation therapy or IMRT}
- A61N 5/1049: {for verifying the position of the patient with respect to the radiation beam}
- A61N 5/1065: {Beam adjustment}
- A61N 5/1067: {in real time, i.e. during treatment}
- A61N 5/1069: {Target adjustment, e.g. moving the patient support}
- A61N 5/107: {in real time, i.e. during treatment}
- A61N 5/1081: {Rotating beam systems with a specific mechanical construction, e.g. gantries}
- A61N 5/1036: {Leaf sequencing algorithms}
- A61N 5/1039: {using functional images, e.g. PET or MRI}
- A61N 5/1075: {for testing, calibrating, or quality assurance of the radiation treatment apparatus}
- A61N 2005/1019: {Sources therefor}
- A61N 2005/1041: {using a library of previously administered radiation treatment applied to other patients}
- A61N 2005/1052: {using positron emission tomography [PET] single photon emission computer tomography [SPECT] imaging}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Systems and methods for shuttle mode radiation delivery are described herein. One method for radiation delivery comprises moving the patient platform through the patient treatment region multiple times during a treatment session. This may be referred to as patient platform or couch shuttling (i.e., couch shuttle mode). Another method for radiation delivery comprises moving the therapeutic radiation source jaw across a range of positions during a treatment session. The jaw may move across the same range of positions multiple times during a treatment session. This may be referred to as jaw shuttling (i.e., jaw shuttle mode). Some methods combine couch shuttle mode and jaw shuttle mode. Methods of dynamic or pipelined normalization are also described.

## Claims

### Claim at position 1

1-29. (canceled)

### Claim 30

A method for updating a treatment plan fluence map, the method comprising:
acquiring PET imaging data originating from a target region using time-of-flight (TOF) PET detectors;
identifying a location of the target region from the acquired PET imaging data; and
updating a treatment plan fluence map for irradiating the target region using the identified location.

### Claim 31 (depends on 30)

The method of claim 30, wherein the PET imaging data comprises line-of-response (LOR) data.

### Claim 32 (depends on 30)

The method of claim 30, further comprising acquiring MV detector data, and wherein updating the treatment plan fluence map uses the acquired MV detector data.

### Claim 33 (depends on 30)

The method of claim 30, further comprising delivering radiation to the target region according to the updated treatment plan fluence map using a therapeutic radiation source.

### Claim 34 (depends on 33)

The method of claim 33, wherein delivering radiation to the target region comprises adjusting a speed of a couch while the therapeutic radiation source is emitting radiation.

### Claim 35 (depends on 34)

The method of claim 34, wherein delivering radiation occurs in at least two separate passes of the couch through radiation emitted by the therapeutic radiation source during the treatment session.

### Claim 36 (depends on 35)

The method of claim 35, wherein updating the treatment plan fluence map comprises updating the treatment plan fluence map after a first couch pass and updating the treatment plan fluence map after a second couch pass.

### Claim 37 (depends on 36)

The method of claim 36, wherein updating the treatment plan fluence map comprises scaling a planned fluence using one or more of a normalization factor, a dampening factor, and a weighting factor one or more times during the treatment session.

### Claim 38 (depends on 37)

The method of claim 37, wherein the normalization factor is dynamically updated for the second couch pass based on radiation delivered during the first couch pass.

### Claim 39 (depends on 30)

The method of claim 30, wherein updating the treatment plan fluence map comprises scaling a planned fluence using one or more of a normalization factor, a dampening factor, and a weighting factor.

### Claim 40 (depends on 30)

The method of claim 30, wherein updating the treatment plan fluence map comprises updating radiotherapy system instructions, wherein radiotherapy system instructions comprise one or more of jaw, multi-leaf collimator, couch, and/or gantry instructions.

### Claim 41 (depends on 30)

The method of claim 30, further comprising calculating a fluence previously delivered to the target region and comparing the previously delivered fluence to the treatment plan fluence map to calculate a fluence difference, and wherein updating the treatment plan fluence map comprises adjusting radiation delivery to deliver the calculated fluence difference.

### Claim 42 (depends on 41)

The method of claim 41, further comprising determining dose artifacts in the previously delivered fluence, and wherein updating the treatment plan fluence map comprises adjusting radiation delivery to correct the dose artifacts.

### Claim 43 (depends on 30)

The method of claim 30, wherein acquiring PET data, identifying the location of the target region, and updating the treatment plan fluence map occur during a single treatment session.

### Claim 44 (depends on 39)

The method of claim 39, wherein the normalization factor and/or dampening factor and/or weighting factor are determined based on an intensity of the PET imaging data originating from the target region.
